Caplin M - Search Results

1

Progressive epigenetic dysregulation in neuroendocrine tumour liver metastases.

Karpathakis A, Dibra H, Pipinikas C, Feber A, Morris T, Francis J, Oukrif D, Mandair D, Pericleous M, Mohmaduvesh M, Serra S, Ogunbiyi O, Novelli M, Luong T, Asa SL, Kulke M, Toumpanakis C, Meyer T, Caplin M, Beck S, Thirlwell C. Karpathakis A, et al. Among authors: caplin m. Endocr Relat Cancer. 2017 Feb;24(2):L21-L25. doi: 10.1530/ERC-16-0419. Epub 2017 Jan 3. Endocr Relat Cancer. 2017. PMID: 28049633 No abstract available.

2

Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumor.

Watson SA, Clarke PA, Morris TM, Caplin ME. Watson SA, et al. Among authors: caplin me. Cancer Res. 2000 Oct 15;60(20):5902-7. Cancer Res. 2000. PMID: 11059789

3

Goblet cell carcinoid tumors (adenocarcinoid) of the appendix.

Toumpanakis C, Standish RA, Baishnab E, Winslet MC, Caplin ME. Toumpanakis C, et al. Dis Colon Rectum. 2007 Mar;50(3):315-22. doi: 10.1007/s10350-006-0762-4. Dis Colon Rectum. 2007. PMID: 17195086

4

Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours.

Toumpanakis C, Meyer T, Caplin ME. Toumpanakis C, et al. Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):131-44. doi: 10.1016/j.beem.2007.01.005. Best Pract Res Clin Endocrinol Metab. 2007. PMID: 17382269 Review.

5

Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century.

Bhattacharyya S, Toumpanakis C, Caplin ME, Davar J. Bhattacharyya S, et al. Am J Cardiol. 2008 Feb 1;101(3):378-81. doi: 10.1016/j.amjcard.2007.08.045. Epub 2007 Dec 21. Am J Cardiol. 2008. PMID: 18237604

6

Molecular genetics of gastroenteropancreatic neuroendocrine tumors.

Toumpanakis CG, Caplin ME. Toumpanakis CG, et al. Am J Gastroenterol. 2008 Mar;103(3):729-32. doi: 10.1111/j.1572-0241.2007.01777.x. Am J Gastroenterol. 2008. PMID: 18341492 Review.

7

The role of 99mTc-depreotide in the management of neuroendocrine tumours.

Shah T, Kulakiene I, Quigley AM, Warbey VS, Srirajaskanthan R, Toumpanakis C, Hochhauser D, Buscombe J, Caplin ME. Shah T, et al. Nucl Med Commun. 2008 May;29(5):436-40. doi: 10.1097/MNM.0b013e3282f50747. Nucl Med Commun. 2008. PMID: 18391727

8

Alpha-fetoprotein and human chorionic gonadotrophin-beta as prognostic markers in neuroendocrine tumour patients.

Shah T, Srirajaskanthan R, Bhogal M, Toubanakis C, Meyer T, Noonan A, Witney-Smith C, Amin T, Bhogal P, Sivathasan N, Warner B, Hochhauser D, Caplin ME. Shah T, et al. Among authors: caplin me. Br J Cancer. 2008 Jul 8;99(1):72-7. doi: 10.1038/sj.bjc.6604428. Epub 2008 Jun 24. Br J Cancer. 2008. PMID: 18577995 Free PMC article.

9

Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review.

Srirajaskanthan R, McStay M, Toumpanakis C, Meyer T, Caplin ME. Srirajaskanthan R, et al. Among authors: caplin me. Neuroendocrinology. 2009;89(1):48-55. doi: 10.1159/000151222. Epub 2008 Aug 5. Neuroendocrinology. 2009. PMID: 18679021 Review.

10

Usefulness of N-terminal pro-brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease.

Bhattacharyya S, Toumpanakis C, Caplin ME, Davar J. Bhattacharyya S, et al. Am J Cardiol. 2008 Oct 1;102(7):938-42. doi: 10.1016/j.amjcard.2008.05.047. Epub 2008 Jul 17. Am J Cardiol. 2008. PMID: 18805126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters